技术文章

4-Bromo-8-(trifluoromethoxy)quinoline: Properties & Applications

4-Bromo-8-(trifluoromethoxy)quinoline is a halogenated, fluorine-containing quinoline building block valued in synthetic and medicinal chemistry for its dual electrophilic handle and electron-withdrawing trifluoromethoxy substituent.

Chemical Name
4-Bromo-8-(trifluoromethoxy)quinoline
SKU
B732558
Molecular Formula
C10H5BrF3NO
Key Functional Groups
C–Br bond at position 4; trifluoromethoxy (–OCF3) group at position 8
Primary Utility
Electrophilic coupling partner in Pd- and Cu-catalyzed cross-coupling reactions; scaffold for drug discovery
Storage Recommendation
Store in a cool, dry place away from light and moisture (verify with SDS)

Chemical Structure and Key Properties

4-Bromo-8-(trifluoromethoxy)quinoline is a bicyclic aromatic heterocycle built on the quinoline scaffold — a benzene ring fused to a pyridine ring. Two electronically significant substituents distinguish this compound: a bromine atom at the 4-position and a trifluoromethoxy (–OCF3) group at the 8-position.

The C–Br bond at position 4 provides a reactive site for transition-metal-catalyzed cross-coupling reactions, nucleophilic aromatic substitution, and metal–halogen exchange. The –OCF3 group at position 8 is a strongly electron-withdrawing substituent that influences the electron density of the ring system, enhances lipophilicity relative to analogous methoxy compounds, and improves metabolic stability — characteristics that are highly desirable in drug-candidate design.

The combination of the electron-deficient quinoline nitrogen and the –OCF3 group renders the aromatic system particularly susceptible to nucleophilic attack at activated positions, further broadening the compound's synthetic utility.

Synthetic Applications and Reactivity

The aryl bromide functionality makes 4-Bromo-8-(trifluoromethoxy)quinoline a versatile electrophilic partner in a wide range of metal-catalyzed transformations commonly employed in modern synthetic chemistry:

  • Suzuki–Miyaura Coupling: Reaction with aryl- or heteroarylboronic acids under palladium catalysis affords biaryl and heteroaryl-quinoline products useful as pharmacophores or ligand scaffolds.
  • Buchwald–Hartwig Amination: Pd-catalyzed C–N bond formation with primary or secondary amines enables rapid construction of aminoquinoline derivatives, a privileged class in kinase inhibitor design.
  • Sonogashira Coupling: Cross-coupling with terminal alkynes under Pd/Cu catalysis introduces alkynyl groups, facilitating access to diverse quinoline-acetylene hybrids.
  • Metal–Halogen Exchange: Treatment with n-BuLi or other organolithium reagents at low temperature generates an aryllithium species that can be trapped with a broad range of electrophiles, providing rapid diversification of the quinoline core.
  • Nucleophilic Aromatic Substitution (SNAr): The electron-withdrawing quinoline nitrogen and –OCF3 group activate the ring toward SNAr with strong nucleophiles such as amines or alkoxides.

These reaction pathways make the compound an efficient gateway to structurally diverse quinoline libraries for high-throughput screening campaigns.

Role of the Trifluoromethoxy Group in Drug Discovery

The –OCF3 group has emerged as one of the most strategically valuable substituents in modern medicinal chemistry. Its incorporation into drug candidates confers several pharmacokinetic and pharmacodynamic advantages:

  • Metabolic Stability: The strong C–F bonds within –OCF3 are highly resistant to oxidative metabolism by cytochrome P450 enzymes, prolonging the half-life of candidate molecules.
  • Lipophilicity Modulation: –OCF3 raises logP relative to –OCH3, improving membrane permeability, which can enhance oral bioavailability.
  • Electron-Withdrawing Effect: The strong inductive withdrawal lowers pKa of adjacent acidic protons and modulates receptor/enzyme binding affinity by altering electronic complementarity with the target.
  • Bioisosterism: –OCF3 can serve as a bioisostere for –OCH3 or –CF3 in rational drug design programs, enabling fine-tuning of selectivity profiles.

Within the quinoline scaffold, which itself is present in numerous approved pharmaceuticals including antimalarials and antibacterial agents, the 8-position –OCF3 group creates a unique three-dimensional electronic environment that can be exploited to achieve selectivity among closely related biological targets.

Handling, Safety, and Storage

As with all halogenated and fluorinated research reagents, appropriate laboratory safety practices must be observed when working with 4-Bromo-8-(trifluoromethoxy)quinoline. Researchers are strongly advised to consult the product Safety Data Sheet (SDS) prior to use for current hazard classifications, exposure limits, and first-aid measures.

General precautions include:

  • Use in a well-ventilated fume hood to minimize inhalation exposure.
  • Wear appropriate personal protective equipment (PPE): nitrile gloves, safety glasses, and a laboratory coat.
  • Avoid contact with skin, eyes, and mucous membranes.
  • Store in a cool, dry location away from moisture, light, and incompatible materials in accordance with SDS guidance.
  • Dispose of waste in compliance with local institutional and regulatory requirements for halogenated organic waste.

Researchers should verify current hazard data directly from the SDS provided by Aladdin Scientific, as regulatory classifications may be updated.

Frequently asked questions

What cross-coupling reactions are compatible with 4-Bromo-8-(trifluoromethoxy)quinoline?

The compound is compatible with a broad range of palladium- and copper-catalyzed cross-coupling reactions, including Suzuki–Miyaura (with boronic acids), Buchwald–Hartwig (C–N bond formation with amines), and Sonogashira (with terminal alkynes) couplings. Metal–halogen exchange with organolithium reagents is also feasible at low temperatures. Researchers should optimize catalytic conditions for their specific substrate combination.

Why is the trifluoromethoxy group important in drug discovery applications?

The –OCF3 group enhances metabolic stability by resisting cytochrome P450-mediated oxidation, increases lipophilicity to improve membrane permeability, and exerts a strong electron-withdrawing effect that can modulate binding affinity at biological targets. It can also serve as a bioisostere for –OCH3 or –CF3 groups in rational drug design, enabling fine-tuning of pharmacokinetic and selectivity profiles.

How should 4-Bromo-8-(trifluoromethoxy)quinoline be stored to maintain stability?

The compound should be stored in a cool, dry location away from moisture, direct light, and incompatible materials. Always consult the current Safety Data Sheet (SDS) provided by Aladdin Scientific for specific storage temperature requirements, container recommendations, and any updated stability data before use.

What is the significance of the bromine at the 4-position of the quinoline ring?

The bromine at the 4-position serves as the primary reactive handle for synthetic elaboration. Position 4 on the quinoline ring is inherently electrophilic due to the ring nitrogen, making the C–Br bond especially reactive toward oxidative addition in palladium catalysis and toward nucleophilic displacement. This regioselectivity allows chemists to functionalize the molecule predictably and efficiently in one synthetic step.

References

  1. Roughley, S. D.; Jordan, A. M. The Medicinal Chemist's Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates. J. Med. Chem. 2011, 54, 3451–3479. doi:10.1021/jm200187y
  2. Müller, K.; Faeh, C.; Diederich, F. Fluorine in Pharmaceuticals: Looking Beyond Intuition. Science 2007, 317, 1881–1886. doi:10.1126/science.1142218
  3. Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Fluorine in Medicinal Chemistry. Chem. Soc. Rev. 2008, 37, 320–330. doi:10.1039/b610213c
  4. Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Palladium-Catalyzed Cross-Coupling Reactions in Total Synthesis. Angew. Chem. Int. Ed. 2005, 44, 4442–4489. doi:10.1002/anie.200500368

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《4-Bromo-8-(trifluoromethoxy)quinoline: Properties & Applications》. 阿拉丁知识库,更新于 2026年10月22日。 https://www.aladdin-e.com/zh_cn/faqs/4-bromo-8-trifluoromethoxy-quinoline-properties-applications-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助